{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:58:13Z","timestamp":1792058293961,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":3520,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s13311-013-0216-3","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T10:48:02Z","timestamp":1379069282000},"page":"188-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Treatment of Myoclonus"],"prefix":"10.1016","volume":"11","author":[{"given":"John N.","family":"Caviness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-013-0216-3_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","article-title":"Myoclonus: current concepts and recent advances","volume":"3","author":"Caviness","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib2","series-title":"Movement disorders","first-page":"196","article-title":"The nosology and pathophysiology of myoclonus","author":"Marsden","year":"1983"},{"key":"10.1007\/s13311-013-0216-3_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.22425","article-title":"Myoclonus-dystonia syndrome: an update","volume":"24","author":"Kinugawa","year":"2009","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4065\/74.6.565","article-title":"The incidence and prevalence of myoclonus in Olmsted County, Minnesota","volume":"74","author":"Caviness","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1007\/s13311-013-0216-3_bib5","unstructured":"Caviness JN. Treatment of myoclonus. In: UpToDate. Available at: www.UpToDateInc.com Accessed April 8, 2013"},{"key":"10.1007\/s13311-013-0216-3_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S1474-4422(10)70193-9","article-title":"Management of patients with myoclonus: available therapies and the need for an evidence-based approach","volume":"9","author":"Dijk","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<321::AID-MUS3>3.0.CO;2-3","article-title":"Electrophysiologic studies of myoclonus","volume":"23","author":"Shibasaki","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-013-0216-3_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.wco.0000162856.75391.b1","article-title":"Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy","volume":"18","author":"Zifkin","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.410370204","article-title":"Basic mechanisms of generalized absence seizures","volume":"37","author":"Snead","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jnnp.57.7.797","article-title":"In vivo demonstration of altered benzodiazepine receptor density in patients with generalized epilepsy","volume":"57","author":"Savic","year":"1994","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1007\/s13311-013-0216-3_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1212\/01.wnl.0000336969.98241.17","article-title":"Nerve fiber impairment of anterior thalamocortical circuitry in juvenile myoclonic epilepsy","volume":"71","author":"Deppe","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib12","series-title":"Movement disorders. Handbook of clinical neurophysiology","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1567-4231(09)70180-7","article-title":"Clinical neurophysiology of myoclonus","author":"Caviness","year":"2003"},{"key":"10.1007\/s13311-013-0216-3_bib13","series-title":"Atlas of video-EEG monitoring","first-page":"309","article-title":"Epileptic myoclonus","author":"Caviness","year":"2011"},{"issue":"13","key":"10.1007\/s13311-013-0216-3_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/01.wnl.0000297516.98574.c0","article-title":"Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations","volume":"70","author":"Roze","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-013-0216-3_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mds.870120328","article-title":"Electrophysiological observations in idiopathic opsoclonus-myoclonus syndrome","volume":"12","author":"Gwinn","year":"1997","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.42.1.52","article-title":"Uraemic myoclonus: an example of reticular reflex myoclonus?","volume":"42","author":"Chadwick","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0216-3_bib17","series-title":"Hyperkinetic movement disorders: differential diagnosis and treatment","first-page":"221","article-title":"Segmental myoclonus","author":"Caviness","year":"2012"},{"key":"10.1007\/s13311-013-0216-3_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10790268.2006.11753891","article-title":"Spinal myoclonus after spinal cord injury","volume":"29","author":"Calancie","year":"2006","journal-title":"J Spinal Cord Med"},{"key":"10.1007\/s13311-013-0216-3_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","article-title":"Amelioration of spinal myoclonus with levetiracetam","volume":"73","author":"Keswani","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0216-3_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.52.1.211","article-title":"Focal cortical transient preceding myoclonus during lithium and tricyclic antidepressant therapy","volume":"52","author":"Evidente","year":"1999","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2011.09.036","article-title":"Reversible propriospinal myoclonus due to thoracic disc herniation: long-term follow-up","volume":"313","author":"Jang","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-013-0216-3_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00314349","article-title":"Post-hypoxic action (intention) myoclonus: a clinic-electroencephalographic study","volume":"235","author":"Witte","year":"1988","journal-title":"J Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mds.870080112","article-title":"Effectiveness of piracetam in cortical myoclonus","volume":"8","author":"Brown","year":"1993","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.870110615","article-title":"Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan","volume":"11","author":"Ikeda","year":"1996","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.64.3.344","article-title":"Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomized, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo","volume":"64","author":"Koskiniemi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1007\/s13311-013-0216-3_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.58.5.781","article-title":"Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy","volume":"58","author":"Fedi","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.57.6.1112","article-title":"A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus","volume":"57","author":"Frucht","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1684\/j.1950-6945.2000.tb00445.x","article-title":"Antimyoclonic effect of levetiracetam","volume":"2","author":"Genton","year":"2000","journal-title":"Epileptic Disord"},{"key":"10.1007\/s13311-013-0216-3_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00702-007-0788-3","article-title":"Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus","volume":"114","author":"Tai","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1007\/s13311-013-0216-3_bib30","first-page":"47","article-title":"Brivaracetam in patients with Unverricht-Lundborg disease, results from two randomized, placebo-controlled, double-blind studies","volume":"50","author":"Kalviaiinen","year":"2009","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1986.tb03525.x","article-title":"Valproate reduces excitability by blockage of sodium and potassium conductance","volume":"27","author":"VanDongen","year":"1986","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/112.3.765","article-title":"The treatment of severe action myoclonus","volume":"112","author":"Obeso","year":"1988","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0216-3_bib33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2013.03.016","article-title":"Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia","volume":"19","author":"Silver","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-013-0216-3_bib34","first-page":"687","article-title":"Drugs acting on amino acid neurotransmitters","volume":"43","author":"Meldrum","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib35","first-page":"629","article-title":"Mechanism of Action of clonazepam in myoclonus in relation to effects on GABA and 5-HT","volume":"43","author":"Jenner","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib36","first-page":"645","article-title":"Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex","volume":"43","author":"Wagner","year":"1986","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(97)00069-7","article-title":"Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients","volume":"29","author":"Kyllerman","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1007\/s13311-013-0216-3_bib38","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","article-title":"A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor","volume":"65","author":"Frucht","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00019052-199704000-00008","article-title":"Generalized epilepsies: emerging insights into cellular and genetic mechanisms","volume":"10","author":"Hosford","year":"1997","journal-title":"Curr Opin Neurol"},{"issue":"Suppl. 2","key":"10.1007\/s13311-013-0216-3_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1528-1157.44.s.2.2.x","article-title":"From molecules to networks: cortical\/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy","volume":"44","author":"Blumenfeld","year":"2003","journal-title":"Epilepsia"},{"issue":"Suppl. 9","key":"10.1007\/s13311-013-0216-3_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1167.2005.00312.x","article-title":"Seizures of idiopathic generalized epilepsies","volume":"46","author":"Duron","year":"2005","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(97)00080-6","article-title":"Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide","volume":"29","author":"Wallace","year":"1998","journal-title":"Epilepsy Res"},{"issue":"Suppl. 3","key":"10.1007\/s13311-013-0216-3_bib43","first-page":"S65","article-title":"Juvenile myoclonic epilepsy: response to valproate monotherapy in 27 previously untreated patients","volume":"36","author":"Christe","year":"1995","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"key":"10.1007\/s13311-013-0216-3_bib45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1982.tb05085.x","article-title":"Sodium valproate: monotherapy and polytherapy","volume":"23","author":"Covanis","year":"1982","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1059-1311(96)80110-5","article-title":"The use of lamotrigine in juvenile myoclonic epilepsy","volume":"5","author":"Buchanan","year":"1996","journal-title":"Seizure"},{"key":"10.1007\/s13311-013-0216-3_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/01.wnl.0000174517.21383.36","article-title":"Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies","volume":"65","author":"Crespel","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1388-2457(03)00327-4","article-title":"Electrophysiological characterization of spontaneous and carbamazepine-induced epileptic negative myoclonus in benign childhood epilepsy with centro-temporal spikes","volume":"115","author":"Parmeggiani","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"Suppl. 11","key":"10.1007\/s13311-013-0216-3_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.44.s11.5.x","article-title":"Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures","volume":"44","author":"Wheless","year":"2003","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-013-0216-3_bib50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.54.5.1201","article-title":"Intravenous valproic acid for myoclonic status epilepticus","volume":"54","author":"Sheth","year":"2000","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1567-424X(09)70380-0","article-title":"Myoclonic epilepsies: syndromes and their treatment","volume":"57","author":"Pellock","year":"2004","journal-title":"Suppl Clin Neurophysiol"},{"key":"10.1007\/s13311-013-0216-3_bib52","first-page":"307","article-title":"Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood","volume":"95","author":"Medina","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib53","first-page":"289","article-title":"Treatment of myoclonic epilepsies in infancy and early childhood","volume":"95","author":"Sankar","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mds.870100106","article-title":"The movement disorder syndrome of adult opsoclonus","volume":"10","author":"Caviness","year":"1995","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib55","first-page":"253","article-title":"Therapy of myoclonus","volume":"3","author":"Obeso","year":"1996","journal-title":"Clin Neurosci"},{"key":"10.1007\/s13311-013-0216-3_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.25326","article-title":"Surgical treatment of myoclonus dystonia syndrome","volume":"28","author":"Rughani","year":"2013","journal-title":"Mov Disord"},{"issue":"4","key":"10.1007\/s13311-013-0216-3_bib57","first-page":"520","article-title":"Treatment of idiopathic opsoclonus-myoclonus with intravenous immunoglobulin","volume":"52","author":"Aysun","year":"2004","journal-title":"Neurol India"},{"key":"10.1007\/s13311-013-0216-3_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198803000-00003","article-title":"Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome","volume":"67","author":"Anderson","year":"1988","journal-title":"Medicine"},{"key":"10.1007\/s13311-013-0216-3_bib59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archneur.1986.00520110055016","article-title":"Opsoclonus in adults","volume":"43","author":"Digre","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib60","first-page":"359","article-title":"Opsoclonus-polymyoclonia syndrome suppressed with reserpine","volume":"38","author":"Harada","year":"1986","journal-title":"Brain Nerve"},{"key":"10.1007\/s13311-013-0216-3_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/brain\/100.3.455","article-title":"Clinical, biochemical and physiological factors distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan plus a monoamine oxidase inhibitor, and clonazepam","volume":"100","author":"Chadwick","year":"1977","journal-title":"Brain"},{"key":"10.1007\/s13311-013-0216-3_bib62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.0b013e3181a0fd50","article-title":"Propriospinal myoclonus revisited: clinical, neurophysiologic, and neuroradiologic findings","volume":"72","author":"Roze","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib63","first-page":"678","article-title":"Propriospinal myoclonus in tetraplegic patients: clinical, electrophysiological and therapeutic aspects","volume":"33","author":"Fouillet","year":"1995","journal-title":"Paraplegia"},{"key":"10.1007\/s13311-013-0216-3_bib64","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-010-5531-6","article-title":"Axial jerks: a clinical spectrum ranging from propriospinal to psychogenic myoclonus","volume":"257","author":"Van der Salm","year":"2010","journal-title":"J Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archneur.1986.00520100039012","article-title":"Segmental myoclonus. Clinical and pharmacologic study","volume":"43","author":"Jankovic","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000064962","article-title":"A case of voluntary palatal myoclonus with ear click: relationship between palatal myoclonus and click","volume":"48","author":"Wakata","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1590\/S0004-282X2000000500017","article-title":"Palatal myoclonus: report of two cases","volume":"58","author":"Fabiani","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1007\/s13311-013-0216-3_bib68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.870110628","article-title":"Treatment of palatal myoclonus with sumatriptan","volume":"11","author":"Scott","year":"1996","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/seiz.2002.0592","article-title":"Palatal myoclonus responding to lamotrigine","volume":"11","author":"Nasr","year":"2002","journal-title":"Seizure"},{"key":"10.1007\/s13311-013-0216-3_bib70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00129492-200309000-00003","article-title":"Treatment for severe palatoclonus by occlusion of the eustachian tube","volume":"24","author":"Ensink","year":"2003","journal-title":"Otol Neurotol"},{"key":"10.1007\/s13311-013-0216-3_bib71","first-page":"672","article-title":"Treatment of essential palatal myoclonus in a 10-year-old girl with botulinum neurotoxin","volume":"27","author":"Krause","year":"2006","journal-title":"Otol Neurotol"},{"key":"10.1007\/s13311-013-0216-3_bib72","first-page":"392","article-title":"(2002) Botulinum toxin injection for objective tinnitus from palatal myoclonus: a case report","volume":"85","author":"Srirompotong","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1007\/s13311-013-0216-3_bib73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00415-006-0039-9","article-title":"Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature","volume":"253","author":"Penney","year":"2006","journal-title":"J Neurol"},{"key":"10.1007\/s13311-013-0216-3_bib74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.73.4.457","article-title":"Amelioration of spinal myoclonus with levetiracetam","volume":"73","author":"Keswani","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-013-0216-3_bib75","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1212\/01.wnl.0000246115.54997.1b","article-title":"Spinal myoclonus following herpes zoster radiculitis","volume":"68","author":"Estraneo","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-013-0216-3_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1531-8257(199901)14:1<182::AID-MDS1040>3.0.CO;2-8","article-title":"Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A","volume":"14","author":"Lagueny","year":"1999","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.20770","article-title":"Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm","volume":"36","author":"Valls-Sole","year":"2007","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1007\/s13311-013-0216-3_bib78","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/mds.870130620","article-title":"Myoclonus associated with thoracodorsal neuropathy","volume":"13","author":"Carnero-Pardo","year":"1998","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-013-0216-3_bib79","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2009.11.021","article-title":"Physiology of psychogenic movement disorders","volume":"17","author":"Hallett","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1007\/s13311-013-0216-3_bib80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/WCO.0b013e3283551bc1","article-title":"Functional (psychogenic) movement disorders","volume":"25","author":"Czarnecki","year":"2012","journal-title":"Curr Opin Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0216-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-013-0216-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923016495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0216-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:00Z","timestamp":1761808200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923016495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1878747923016495"],"URL":"https:\/\/doi.org\/10.1007\/s13311-013-0216-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Myoclonus","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-013-0216-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}